Average Co-Inventor Count = 5.78
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (20 from 3,923 patents)
2. Bayer Aktiengesellschaft (5 from 12,157 patents)
3. Bayer Schering Pharma Ag (2 from 192 patents)
4. Other (1 from 832,680 patents)
5. Bayer Intellectual Property Gmbh (1 from 721 patents)
6. Beiersdorf Ag (1 from 538 patents)
7. Bayer Aktiengeselischaft (1 from 2 patents)
31 patents:
1. 12226405 - Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
2. 11702409 - Pyrazolyl derivatives useful as anti-cancer agents
3. 9890166 - Imidazopyrrolidine derivatives and their use in the treatment of disease
4. 9556180 - Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
5. 9550796 - Pyrrolopyrrolone derivatives and their use as BET inhibitors
6. 9403827 - Substituted purinone compounds
7. 9365576 - Pyrrolopyrrolidinone compounds
8. 8975417 - Pyrazolopyrrolidine derivatives and their use in the treatment of disease
9. 8969341 - Pyrazolopyrrolidine compounds
10. 8815926 - Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
11. 8748435 - Pyrazolo pyrimidine derivatives
12. 8242281 - Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
13. 8133886 - Heterobicyclic carboxamides as inhibitors for kinases
14. 8058276 - Heterobicyclic carboxamides as inhibitors for kinases
15. 8053457 - 3-imidazolyl-indoles for the treatment of proliferative diseases